Journal Report

BREAST

Download PDF
Journal Information
Journal Title
BREAST
Publisher
CHURCHILL LIVINGSTONE
ISSN
0960-9776
E-ISSN
1532-3080
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Cost-effectiveness of abbreviated breast MRI and contrast-enhanced mammography for women with extremely dense breasts in a national breast cancer screening program: a micro-simulation study
Mengmeng Li, Marcel J.W. Greuter, Keris Poelhekken et al.
2026-12 Vol. 90 Pages 104907
DOI: 10.1016/j.breast.2026.104907
Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort
Thomas Grinda, Matthieu Carton, Stefania Morganti et al.
2026-12 Vol. 90 Pages 104943
DOI: 10.1016/j.breast.2026.104943
To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission
Han Yi Lee, Whee Sze Ong, Vivianne Tjan-Heijnen et al.
2026-12 Vol. 90 Pages 104935
DOI: 10.1016/j.breast.2026.104935
Analysis of outcomes of nab-paclitaxel compared to other taxanes in early breast cancer: A study revealing the critical role of calendar-time bias in real-world drug comparisons
Jingjing Xiao, Meiling Huang, Changjiao Yan et al.
2026-12 Vol. 90 Pages 104934
DOI: 10.1016/j.breast.2026.104934
Pembrolizumab plus chemotherapy followed by pembrolizumab in participants in Asia with early triple-negative breast cancer: An updated subgroup analysis of the KEYNOTE-522 randomized clinical trial
Yeon Hee Park, Rina Hui, Seock-Ah Im et al.
2026-12 Vol. 90 Pages 104904
DOI: 10.1016/j.breast.2026.104904
Prospective assessment of incomplete ovarian suppression in breast cancer using LC-MS/MS and immunoassays for estradiol
Catherine M. Kelly, Lajos Pusztai, Kathleen Bennett et al.
2026-12 Vol. 90 Pages 104937
DOI: 10.1016/j.breast.2026.104937
Transcriptomic signatures of mind-body transformations therapy in breast cancer: Downregulation of the interferon signaling pathway
Stefania Cocco, Mauro Cozzolino, Michela Piezzo et al.
2026-12 Vol. 90 Pages 104912
DOI: 10.1016/j.breast.2026.104912
Which quality of life issues are important to patients with metastatic breast cancer: Phase 1 and 2 development of European Organisation for Research and Treatment of Cancer metastatic breast cancer module (EORTC QLQ-MBR)
Christopher Bedding, Kate Absolom, Katarzyna Pogoda et al.
2026-12 Vol. 90 Pages 104911
DOI: 10.1016/j.breast.2026.104911
Prognostic role of thymidine kinase 1 activity in hormone receptor positive metastatic breast cancer. A systematic review and meta-analysis
Ilenia Migliaccio, Roberto Buonaiuto, Giulia Anichini et al.
2026-12 Vol. 90 Pages 104914
DOI: 10.1016/j.breast.2026.104914
Subtype-specific screen-detected and interval breast cancer rates in population screening: a BreastScreen Queensland cohort study
Naomi Noguchi, Nick Ormiston-Smith, Michael Luke Marinovich et al.
2026-12 Vol. 90 Pages 104938
DOI: 10.1016/j.breast.2026.104938
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 2, 2026 20:44